chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Menstruation in the middle of birth control pack 5 days after receiving final vaccine on 20Apr2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Apr2021 10:00 (Lot number: ER8734) at the age of 26 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Birth control" (unspecified if ongoing). Concomitant medication(s) included: ZOLOFT. Vaccination history included: Bnt162b2 (Product: COVID 19, Pfizer, Lot number: er8734, lot unknown: False, Administration date: 22Mar2021, Administration time: 10:00 AM, Dose number 1, Vaccine location: Left arm), administration date: 22Mar2021, when the patient was 26 years old, for Covid-19 immunization. The following information was reported: MENSTRUATION IRREGULAR (non-serious) with onset 22Apr2021, outcome "recovered" (2021), described as "Menstruation in the middle of birth control pack 5 days after receiving final vaccine on 20Apr2021". Therapeutic measures were not taken as a result of menstruation irregular.  Additional information: The patient took other vaccine (unspecified) on same date as of vaccine 20Apr2021. The patient did not take other vaccine in four weeks. She did not have Covid prior vaccination, also she did not underwent test for Covid post vaccination. She did not have no known allergies. The patient had menstruation in the middle of birth control pack 5 days after receiving final vaccine on 20Apr2021 (PMS symptoms began 2 days after). Periods were always precise/regulated by birth control, so this was very out of the ordinary. She did not think much of it but a friend of her who received her second dose on the same day had the exact same experience.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021482032 same reporter/product/event different patient.
Noticed 2 bumps on hand in AM. Came into health dept for MMR. The next AM, post vax, woke up with more bumps on both arms and rash on left arm, few bumps on both legs and back, bumps are puss filled and itching. Has been to doctor and an appt next week with another MD.
This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC ((Rash is) itchy), RASH ERYTHEMATOUS ((Rash is) red) and RASH (Tiny rash on torso) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC ((Rash is) itchy), RASH ERYTHEMATOUS ((Rash is) red) and RASH (Tiny rash on torso). At the time of the report, RASH PRURITIC ((Rash is) itchy), RASH ERYTHEMATOUS ((Rash is) red) and RASH (Tiny rash on torso) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
About 20 minutes after injection I experienced facial numbness and tingling in addition to tingling in my tongue and throat on the left side which lasted about 2 days and reduced over the course of 2 days.
pt recv vax & had 4 loose stools;pt also devel a white rash on stomach, an inj site rxn characterized by redness & swelling @ site of vax & fitful sleep;1 days post vax devel a cough & congestion which persisted @ the date of this report;
Clotting antibodies and spiked antibodies are extremely high, which means beyond safe normal levels; wellness is lacking; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP), Program ID.  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANTIBODY TEST ABNORMAL (non-serious), outcome "unknown", described as "Clotting antibodies and spiked antibodies are extremely high, which means beyond safe normal levels"; MALAISE (non-serious), outcome "unknown", described as "wellness is lacking". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: Case Category: Patient Assistance Programs. Do you publish reaction protocols for the covid 19 vaccine. My spouse was experiencing a prolonged reaction. Clotting antibodies and spiked antibodies are extremely high, which means beyond safe normal levels. It has taken 9 months to begin reducing them to "high" normal. Her wellness was lacking. Other symptoms are pronounced. Please advise.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
admit 2/20, vaccine 1/15, 2/9. COVID+ at NH week prior to admit, acute encephalopathy, FTT, likely d/t COVID. Palliative care + DC to hospice per family's wishes.
This spontaneous report as received from a pharmacist refers to a twenty eight year old patient who was vaccinated with dose 1 of GARDASIL on 24-NOV-2013. Dose, route, lot and expiry date were unknown. No adverse effects were reported. Additional information has been requested.
severe headache and nausea - lasted approximately 40 hours.  inflammation at injection site - 4" circle - lasted 30 hours. Very sore arm (right arm) muscle aches.
Information has been received from a physician concerning a female child who was vaccinated with a dose of Hepatitis B vaccine recombinant, who had a possible upper respiratory infection at the time of the vaccination. Subsequently, the patient developed urticaria. The patient sought unspecified medical attention. The physician did not feel that the reaction was caused by Hepatitis B vaccine recombinant. Follow up information from a physician indicated that the urticaria started hours after the injection of Hep B vaccine recombinant and "lasting for days". Subsequently, the patient recovered..
roughly  10 hours after receiving the vaccine I woke up not feeling well, I can only describe it as shock/septic shock signs and symptoms symptoms! my fever must have been through the roof because I was so cold I couldn?t even move to get and take some Tylenol! probably about an hour or two after waking up I was able to crawl and take some Tylenol and instantly went back to bed or passed out I woke up a hour later with nausea and vomiting probably once my fever started to come down when making my way to the bathroom I was having trouble standing up from the fever or blood pressure I can?t be certain because I wasn?t able to take my blood pressure. after my vomiting had subsided I took a 1000 mg of Tylenol and didn?t wake up until the next day where signs and symptoms are evident but not severe as the previous night
Information has been received from a nurse concerning a twin patient who on 11-JUN-2009, was exposed through the mother who was vaccinated with the first dose of GARDASIL. On 20-JAN-2010, at approximately 36 weeks of gestation, the twin's mother delivered them by a planned C-section. It was noted that it was a repeat C-section for the mother. The nurse did not known the birth weights of the twin. The nurse also reported that there was nothing mentioned about any problems with either baby. The mother's experience has been captured in WAES 0906USA04966. The brother's experience has been captured in WAES 0906USA04966B1. No further information is available.
Woke from sleep with chest pain and shortness of breath. The pain was worse lying down rather than sitting up. Monitored her (pulse ox finger monitor showed oxygen levels mostly above 96% and HR in the mid-80's) chose not to go to the ER. She did not return to sleep. Symptoms began to lessen around 10:30am, and were gone around 2:30pm.
Pt. received ZOSTAVAX vaccine.  7-10 days later developed rash consistent with hives.
Information has been received from a medical assistant referring to multiple unspecified patients. On multiple unspecified dates the patients were vaccinated for prophylaxis with VAQTA (lot # L023936, expiration date 15-MAR-2017), which was improperly stored at 61.03 F for 3 hours 38 minutes.  The temperatures were not logged with a data logger and there were no previous excursions. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1612USA006816:US-009507513-1612USA004271:US-009507513-1612USA006815:
Narrative:  88 Y/O MALE PRESENTED TO ER ON 1/8/22 FOR DIARREHA FOR 4 DAYS, DYSPEPSIA, FATIGUE, WEAKNESS AND COUGH. TREATED WITH REMDESIVIR AND DEXAMETHASONE. PMH INCLUDES CHRONIC DIARRHEA, HYPERLIPIDEMIA, PROSTATE CANCER, GERD, CHF, PULMONARY HTN, RECURRENT PANCREATITIS.
Pt developed a red rash at site of ZOSTAVAX given. Pt did not feel it and was not in pain. She recovered w/o cry & treatment.
pt recvd vax & devel cough shortly p/that exposure & was treated by MD w/bronchodilator inhaler; 27MAR94 pt devel a rash on arms & torso; seen by MD & was told that the rash was probably related to exposure to bleach & varnish fumes;
5 days after finishing oral typhoid vaccine client awoke with both knees swollen, it was difficult to bend or extend legs at knee. No pain. No Hx of similar jt pain. He may be developing arthritis.
Initially had typical side effect of soreness at injection site that lasted for two days; less soreness than with previous Covid shots.  Began having soft stools/diarrhea on October 27. Number of soft stools/diarrhea varies from 3-8/day. Soft stools/diarrhea continues as of date I am completing this form. Currently seem to have soft stool/diarrhea about 1-2 hours after eating and once in early morning hours (~5am-6am). Had Urgent Care appt on Nov. 8 due to continued diarrhea. Have appt with new PCP on Nov. 21 since lab results following Nov. 8 appt were negative, to continue pursuing cause. Just moved in September so in process of establishing relationships with medical providers. Best doctor to contact regarding adverse event will be  my new PCP, sometime following my appointment with her on Nov. 21.
Soreness on site of shot. Some itch. Fever of 101.9, fatigue, headache, chills, sweatting through the night, muscle pain, stomach ache.
Had a flushed feeling across her chest no shortness of breath or rash  noted .  Was given 50 mg Benadryl   watched for another 30 minutes no other issues.  Stable and is feeling fine.
pt recvd vax 18OCT95 called 20OCT c/o 3" red area that was painful;generally felt lousy but had not taken temp;31OCT95 spoke w/ pt arm did swell up x 4 days, painful 4-5 days;pt saw MD put on PCN dx strep germ
Dizziness, Myalgia, & NauseaVomiting Narrative: Per nursing report: "2nd dose of Moderna on 1-21-21. C/o nausea, lightheadedness and sick to the stomach. States could not move on Friday [1/22] because bodyaching and nauseated. States was not able to come to work. States also states had redness to site of injection. States feels better."
1Mar91-headache T-104 F orally vomiting, 2Mar91-ER visit-, T 102, 3Mar91-T 102 F, 4Mar91-T 102 F, 5Mar91 T 102 F, 6Mar91-T 101 F, 7Mar91-normal
Child had a seizure on the evening following vaccine administration (approximately 10 hours later). Following the seizure, developed spasms later diagnosed as infantile spasms.
This non-valid, spontaneous report was received from a registered nurse, referring to an unspecified number of patients of unknown age and gender. No information was provided regarding the patients' medical history, previous drug reactions, allergies, concurrent medical conditions or concomitant medications. On unknown dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB lot number N034005 (expiration date 31-JAN-2020) and lot number reported as "N021920" (expiration date 07-FEB-2020) for prophylaxis (doses, routes and anatomical locations of administration were not reported). Additionally, the patients were vaccinated with ROTATEQ by oral route, lot number N005078 (expiration dates 22-NOV-2018 and 04-OCT-2018) for prophylaxis (doses were unknown), GARDASIL 9 lot number N020352 (expiration date 10-APR-2020) for prophylaxis (doses, routes and anatomical locations of administration were not provided) and M-M-R II for prophylaxis (dose numbers, routes and anatomical locations of administration were not provided; lot numbers N010496 [expiration date 31-MAR-2019], N014485 [expiration date 10-MAY-2019], and N023149 [expiration date 24-AUG-2019]). The vaccines were reconstituted with sterile diluent which was reported to be properly stored. The doses of all vaccines were exposed to a temperature excursion below 32 degrees Fahrenheit (F) (also reported as 31F) during a time frame of 15 days, which was detected by the Digital Data Logger. There was no prior temperature excursion and no adverse effects were reported. Follow-up information was received from the nurse on 17-DEC-2018. The reporter provided patients' demographics which made the case valid. This report refers to a 12-year-old patient of unknown gender. On 31-MAY-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 lot number N020352 (expiration date 10-APR-2020). This is one of multiple reports received from the same reporter.; Sender's Comments: US-009507513-1807USA011661:
Patient developed cellulitis at injection site next day following injection. Patient started on course of antibiotics 2 days after injection. Patient showed great improvement after 1 1/2 days of antibiotic course.
COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old male patient received BNT162b2 (BNT162B2), in Apr2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of covid-19.  Clinical course: There was no other medication in 2 weeks. Patient took COVID 19 Treatment from 19Jan2023 to 24Jan2023  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
vaginal bleeding for 3-4 hours, moderate on 11/1/2023, then again slight vaginal bleeding for 1-2 hours on 11/2/2023 - I have been using Yuvafem intravaginal dose 2X/week since 3/7/2023 and  experienced no bleeding between that date and yesterday (1/1/2023) - I reported previous episodes of bleeding that seemed to be connected to the Covid vaccinations - my permanent record # is 892534 - my id is 2463466 - this postmenopausal bleeding is more an inconvenience than  a problem at this point, but I checked with my OB/GYN (see above) and she encouraged me to report that it had happened again shortly after getting another covid vaccination
patient came in saying they experienced a reaction shortly after receiving the pneumonia vaccine. Arm became red, swollen, and hot - patient showed us their arm and it was red all the way to elbow - patient visited their doctor who diagnosed cellulitis and prescribed bactrim
Within 24 hours had red, hard bump warm to touch the size of a quarter.  Went away in two days  On March 15- 1 week after vaccine, woke up to small itchy bump on left arm.  Within 1 day grew from size of a dime to over the size of a half dollar coin.  Extremely itchy, red raised bump. I did take Benadryl once  to help with the itching   March 16- bump is bigger , red raised and itchy
3/27/13 Patient awoke with neck pain, neck pain continued to get worse 3/28 & 29 as well as some difficulty in swallowing although no sore throat was noted, she had difficulty bending her neck as well, 3/30 she began with vomiting, nausea and low grade (100 degree F.) temp. She went to ER and received oral PCN which she could not take due to vomiting and had a CBC done. 4/1 she called HD and CHN called Vaccine Hotline at CDC. Call was transferred to pox virus and rabies branch of CDC. On 4/4 hotline consultant returned phone call to CHN and put her in touch with Dr. at pox virus and rabies branch. Consutation with Dr. stated that patient needed to consult with her own physician for medical evaluation and to determine if pre-exposure treatment should continue at patient works in a vetinary hospital. Patient was advised and was recovered.
Tested + for covid on     1-2-23   Admitted on 1-3-23 thru 1-7-23 for UTI, shortness of breath. Had anemia with hb of 6.8 and was tranfused.  Continued on lasix for CHF .  Covid + and stble on room air.  dx back to nursing home. Readmitted on 1-11-2023  thru 1-19-2023   with cough, dyspnea, edema.   Transferred to hospital with  dx hyperkalemia, bilateral pleural effusions, thrombocytopenic disorder, covid, chf    acute on chronic kidney disease (may require dialysis due to the high potassium)        had required intubation  Deceased 1-30-2023
Death. Pt found unresponsive by son, EMS called, pt had pulse but on way to ED found to be in asystole, CPR/Epi with ROSC. The family chose comfort care on 2/5/2022 and the patient was pronounced dead on 2/5/2022 at 1450
Patient had onset of pain and red stool late PM on 11/6/10. He was diagnosed with an intussusception which was reduced by air enema.
Very sore arm (injection arm); low grade fever; chills; body aches (especially back, neck and legs); headache; fatigue; dose_received: 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 17Nov2021 09:00 (Lot number: FF8841) at the age of 45 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Hashimoto''s thyroid disease" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; KEFLEX [CEFALEXIN MONOHYDRATE]. Vaccination history included: Bnt162b2 (dose- 2, lot number=EL3247, route=Intramuscular, location=left arm), administration date: 17Feb2021, when the patient was 45 years old, for Covid-19 immunization; Bnt162b2 (dose-1, lot number=EL3247, route=Other, location=left arm), administration date: 27Jan2021, when the patient was 45 years old, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 17Nov2021, outcome "unknown", described as "dose_received: 3"; PAIN IN EXTREMITY (non-serious) with onset 18Nov2021, outcome "unknown", described as "Very sore arm (injection arm)"; PYREXIA (non-serious) with onset 18Nov2021, outcome "unknown", described as "low grade fever"; CHILLS (non-serious) with onset 18Nov2021, outcome "unknown", described as "chills"; PAIN (non-serious) with onset 18Nov2021, outcome "unknown", described as "body aches (especially back, neck and legs)"; HEADACHE (non-serious) with onset 18Nov2021, outcome "unknown", described as "headache"; FATIGUE (non-serious) with onset 18Nov2021, outcome "unknown", described as "fatigue". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain in extremity, pyrexia, chills, pain, headache, fatigue.  Additional information: The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient received Synthorid, Keflex any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected
I experienced a spike in my blood pressure ( no changes in life style or events)suddenly on 2/7/2023. My normal BP , tested weekly over 6 years ranged from 110-120 over 70-75. The spike was 140-150/ 90-95. BP remained high through week. Following Monday checked in to Urgent Care at Cardiology. They did ECG and blood test and confirmed no apparent heart episode or stroke. BP medicine was revised from Ramipril (5mg) to Losartan K (25 mg) . BP is relatively stable, but higher than it was previous to this (apparent) episode. I am scheduled for a PET Scan on 4/27/23. Last PET scan was March 2020 and showed no blockages in heart. In meantime experiencing no chest pains , shortness of breath etc and am still doing cardio and weight lifting 5-6 times a week. I tested for COVID at home several times during and since episode and all tests negative, I have not contracted the virus ( as far as I know) since it came to the country. I had only mild reactions to all five doses of COVID vaccine ( similar to flu vaccine reaction).
PATIENT FAINTED 9 MINUTES AFTER RECEIVING VACCINATION, REGAINED CONSCIOUSNESS WITHIN 3 MINUTES, WAS COHERENT AND AWARE OF WHAT HAPPENED. PHARMACIST CHECKED PATIENT'S BLOOD PRESSURE (124/97), AND HEART RATE (94), PATIENT LOOKED PALE AND STILL DIZZY AFTER REGAINING CONSCIOUSNESS.
The pt, a 77 year old female, reported that within 3 days, post vax, she developed flu-like symptoms of general aching all over her body, weakness, loss of appetite; physical condition continued to worsen each day. By the 4th day, she experienced difficulty breathing. She was seen in the ER where, after X-ray, 1 liter of fluid was removed from her lung. Eleven days, post vax, she developed itchiness, rashes and small blisters on her back, inner thighs and ankles. The fronts of her legs had red, feverish lumps beneath the surface of skin, with fluid retention around her ankles. The rash subsided within a week, but the heavy welts on her feet and palms of hands and itching persisted for 10 more days. All adverse events, except the ankle edema have completely resolved. The ankle edema continues to be treated with HCTZ, 25 mg per day. The pt stated that the dx of "pleural virus" was made. No additional information is available.